Skip to main navigation Skip to search Skip to main content

Anti-drug antibodies against a novel humanized anti-CD20 antibody impair its therapeutic effect on primary biliary cholangitis in human CD20- and FcγR-expressing mice

  • Yuki Moritoki
  • , Koichi Tsuneyama
  • , Yuka Nakamura
  • , Kentaro Kikuchi
  • , Akira Shiota
  • , Yoshiyuki Ohsugi
  • , Zhe Xiong Lian
  • , Weici Zhang
  • , Guo Xiang Yang
  • , Shigeharu Ueki
  • , Masahide Takeda
  • , Ayumi Omokawa
  • , Tomoo Saga
  • , Akiko Saga
  • , Daisuke Watanabe
  • , Masahito Miura
  • , Yoshiyuki Ueno
  • , Patrick S.C. Leung
  • , Atsushi Tanaka
  • , M. Eric Gershwin
    • Makoto Hirokawa
  • Akita University
  • University of Hawai'i at Mānoa
  • Tokushima University
  • Institute of Immunology Tokyo
  • Ohsugi BioPharma Consulting, Co., Ltd.
  • South China University of Technology
  • University of California at Davis
  • Watanabe Internal Medicine Clinic
  • Omagari Kosei Medical Center
  • Yamagata University

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-drug antibodies against a novel humanized anti-CD20 antibody impair its therapeutic effect on primary biliary cholangitis in human CD20- and FcγR-expressing mice'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Medicine and Dentistry